Commerce Bank Amgen Inc Transaction History

Commerce Bank

$15.3 Billion
Q2 2024

A detailed history of Commerce Bank transactions in Amgen Inc stock. As of the latest transaction made, Commerce Bank holds 376,144 shares of AMGN stock, worth $120 Million. This represents 0.77% of its overall portfolio holdings.

Number of Shares

376,144

Previous 358,881 4.81%

Holding current value

$120 Million

Previous $102 Million 15.18%

% of portfolio

0.77%

Previous 0.68%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $4.54 Million - $5.51 Million	17,263 Added 4.81%	376,144 $118 Million
Q1 2024 May 03, 2024	BUY	$268.87 - $324.56 $3.19 Million - $3.86 Million	11,878 Added 3.42%	358,881 $102 Million
Q4 2023 Feb 09, 2024	BUY	$255.7 - $288.46 $7.69 Million - $8.68 Million	30,082 Added 9.49%	347,003 $99.9 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $3.74 Million - $4.64 Million	-17,100 Reduced 5.12%	316,921 $85.2 Million
Q2 2023 Aug 08, 2023	SELL	$214.27 - $253.37 $7.7 Million - $9.1 Million	-35,925 Reduced 9.71%	334,021 $74.2 Million
Q1 2023 May 04, 2023	BUY	$225.79 - $275.2 $2.16 Million - $2.63 Million	9,554 Added 2.65%	369,946 $89.4 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $4.46 Million - $5.67 Million	19,480 Added 5.71%	360,392 $94.7 Million
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $4.55 Million - $5.14 Million	20,291 Added 6.33%	340,912 $76.8 Million
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $34.1 Million - $38 Million	147,958 Added 85.69%	320,621 $78 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $1.81 Million - $2.01 Million	-8,267 Reduced 4.57%	172,663 $41.8 Million
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $557,858 - $638,418	-2,805 Reduced 1.53%	180,930 $40.7 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $2.09 Million - $2.45 Million	9,847 Added 5.66%	183,735 $39.1 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $1.75 Million - $1.94 Million	-7,500 Reduced 4.13%	173,888 $42.4 Million
Q1 2021 May 05, 2021	SELL	$221.91 - $258.6 $11.4 Million - $13.3 Million	-51,314 Reduced 22.05%	181,388 $45.1 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.94 Million - $2.31 Million	8,952 Added 4.0%	232,702 $53.5 Million
Q3 2020 Nov 06, 2020	SELL	$234.65 - $260.95 $4.44 Million - $4.94 Million	-18,941 Reduced 7.8%	223,750 $56.9 Million
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $1.53 Million - $1.88 Million	-7,729 Reduced 3.09%	242,691 $57.2 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $689,778 - $914,834	3,785 Added 1.53%	250,420 $50.8 Million
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $2.1 Million - $2.7 Million	-11,093 Reduced 4.3%	246,635 $59.5 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $5.18 Million - $6.21 Million	29,752 Added 13.05%	257,728 $49.9 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $495,765 - $581,149	2,974 Added 1.32%	227,976 $42 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $745,003 - $839,781	4,119 Added 1.86%	225,002 $42.7 Million
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $989,406 - $1.15 Million	5,546 Added 2.58%	220,883 $43 Million
Q3 2018 Nov 02, 2018	BUY	$185.29 - $208.89 $1.55 Million - $1.75 Million	8,388 Added 4.05%	215,337 $44.6 Million
Q2 2018 Aug 08, 2018	BUY	$166.05 - $186.51 $398,520 - $447,624	2,400 Added 1.17%	206,949 $38.2 Million
Q1 2018 May 03, 2018	BUY	$169.43 - $198.0 $1.14 Million - $1.33 Million	6,730 Added 3.4%	204,549 $34.9 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $7.86 Million - $8.79 Million	46,586 Added 30.8%	197,819 $34.4 Million
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $6.39 Million - $7.3 Million	-38,204 Reduced 20.17%	151,233 $26 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $31.7 Million - $36.2 Million	189,437	189,437 $35.3 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account